BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1907825)

  • 1. Pharmacology of the pyrroloimidazole, SK&F 105809--II. Antiinflammatory activity and inhibition of mediator production in vivo.
    Griswold DE; Marshall PJ; Lee JC; Webb EF; Hillegass LM; Wartell J; Newton J; Hanna N
    Biochem Pharmacol; 1991 Jul; 42(4):825-31. PubMed ID: 1907825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of the pyrroloimidazole, SK&F 105809--I. Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
    Marshall PJ; Griswold DE; Breton J; Webb EF; Hillegass LM; Sarau HM; Newton J; Lee JC; Bender PE; Hanna N
    Biochem Pharmacol; 1991 Jul; 42(4):813-24. PubMed ID: 1907824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of SK&F 105809, a dual inhibitor of arachidonic acid metabolism.
    Hanna N; Marshall PJ; Newton J; Schwartz L; Kirsh R; Dimartino MJ; Adams J; Bender P; Griswold DE
    Drugs Exp Clin Res; 1990; 16(4):137-47. PubMed ID: 2127565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of inflammatory cell infiltration by bicyclic imidazoles, SK&F 86002 and SK&F 104493.
    Griswold DE; Hoffstein S; Marshall PJ; Webb EF; Hillegass L; Bender PE; Hanna N
    Inflammation; 1989 Dec; 13(6):727-39. PubMed ID: 2559032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
    Griswold DE; Marshall PJ; Webb EF; Godfrey R; Newton J; DiMartino MJ; Sarau HM; Gleason JG; Poste G; Hanna N
    Biochem Pharmacol; 1987 Oct; 36(20):3463-70. PubMed ID: 2823821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonic acid-induced inflammation: inhibition by dual inhibitor of arachidonic acid metabolism, SK&F 86002.
    Griswold DE; Webb E; Schwartz L; Hanna N
    Inflammation; 1987 Jun; 11(2):189-99. PubMed ID: 3108157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
    Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
    Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgetic activity of SK&F 105809, a dual inhibitor of arachidonic acid metabolism.
    Griswold DE; Marshall P; Martin L; Webb EF; Zabko-Potapovich B
    Agents Actions Suppl; 1991; 32():113-7. PubMed ID: 1906235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridinyl imidazoles inhibit the inflammatory phase of delayed type hypersensitivity reactions without affecting T-dependent immune responses.
    Reddy MP; Webb EF; Cassatt D; Maley D; Lee JC; Griswold DE; Truneh A
    Int J Immunopharmacol; 1994 Oct; 16(10):795-804. PubMed ID: 7843851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activity.
    Foster SJ; Bruneau P; Walker ER; McMillan RM
    Br J Pharmacol; 1990 Jan; 99(1):113-8. PubMed ID: 2110012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation in vivo of classical non-steroidal antiinflammatory drugs from cytokine suppressive antiinflammatory drugs and other pharmacological classes using mouse tumour necrosis factor alpha production.
    Griswold DE; Hillegass LM; Breton JJ; Esser KM; Adams JL
    Drugs Exp Clin Res; 1993; 19(6):243-8. PubMed ID: 8013267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response.
    Griswold DE; Webb EF; Breton J; White JR; Marshall PJ; Torphy TJ
    Inflammation; 1993 Jun; 17(3):333-44. PubMed ID: 7687237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine suppressive anti-inflammatory compounds inhibit bone resorption in vitro.
    Votta BJ; Bertolini DR
    Bone; 1994; 15(5):533-8. PubMed ID: 7980964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of corticosterone in modulation of eicosanoid biosynthesis and antiinflammatory activity by 5-lipoxygenase (5-LO) and cyclooxygenase (CO) inhibitors.
    Tomchek LA; Hartman DA; Lewin AC; Calhoun W; Chau TT; Carlson RP
    Agents Actions; 1991 Sep; 34(1-2):20-4. PubMed ID: 1665293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the cutaneous anti-inflammatory activity of azaspiranes.
    Griswold DE; Martin LD; Badger AM; Breton J; Chabot-Fletcher M
    Inflamm Res; 1998 Feb; 47(2):56-61. PubMed ID: 9535542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
    Rao NL; Dunford PJ; Xue X; Jiang X; Lundeen KA; Coles F; Riley JP; Williams KN; Grice CA; Edwards JP; Karlsson L; Fourie AM
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1154-60. PubMed ID: 17371808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic characterization of the antiinflammatory properties of a new dual inhibitor of lipoxygenase and cyclooxygenase.
    DiMartino MJ; Griswold DE; Berkowitz BA; Poste G; Hanna N
    Agents Actions; 1987 Feb; 20(1-2):113-23. PubMed ID: 3107354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.
    Carlson RP; O'Neill-Davis L; Chang J; Lewis AJ
    Agents Actions; 1985 Dec; 17(2):197-204. PubMed ID: 3938181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.